REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarwyn Val. Regulatory News (MVI)

Share Price Information for Marwyn Val. (MVI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 94.50
Bid: 92.00
Ask: 97.00
Change: 0.00 (0.00%)
Spread: 5.00 (5.435%)
Open: 94.50
High: 94.50
Low: 94.50
Prev. Close: 94.50
MVI Live PriceLast checked at -
Marwyn Value Investors is an Investment Trust

To achieve long-term capital appreciation through its investment in the Master Fund primarily by focusing in mid cap businesses headquartered in the UK, Europe or North America.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Investment in Palmer Street Limited

25 May 2023 07:00

RNS Number : 5817A
Marwyn Value Investors Limited
25 May 2023
 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA, JAPAN, ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA OR ANY JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO

 

 

LEI: 213800L5751QTTVEA774

 

25 May 2023

 

This announcement contains inside information

 

Marwyn Value Investors Limited ("MVIL" or the "Company")

 

Investment in Palmer Street Limited

 

MVIL is pleased to announce that funds managed by Marwyn Investment Management LLP have made an investment of £8 million in Palmer Street Limited ("Palmer"). Palmer is being set up to take advantage of the opportunity to provide a differentiated business proposition in the private capital servicing sector.

 

Palmer's management team: Martin Schnaier, James Ireland, James Bermingham, Jason Bingham and Phil Godley have all previously worked in senior leadership roles at FTSE 250 company, Sanne Group plc, that was taken private by Apex Group for £1.5 billion, with the transaction completing in August 2022. Palmer is expected to become an operational business in 2024 reflecting the time for regulatory approvals and compliance with non-compete undertakings. Marwyn will be the lead investor and James Corsellis, Chief Investment Officer of Marwyn Investment Management LLP, will join the Board of Palmer.

 

James Corsellis commented: "We are absolutely delighted to have the opportunity to invest with Martin and his co-founders. As a team they have an exceptional track-record, and we feel privileged that they have chosen Marwyn as their equity partner."

 

Martin Schnaier, CEO of Palmer commented: "We are delighted to partner with Marwyn as we embark upon an exciting new journey to redefine the future of private capital servicing. We believe that the industry has reached an inflection point and a unique market opportunity exists to create a platform capable from inception of meeting the demands of a modern operating environment."

 

For further enquiries, please visit www.wearepalmer.com

 

Notes to editors:

 

Palmer team biographies

 

Martin Schnaier

Martin was formerly the CEO of Sanne Group plc where he led the business through its £1.5 billion public to private transaction in 2022, delivering more than 100% share price growth during his tenure. At completion, Sanne employed over 2,500 people located in 23 offices across North America, EMEA and Asia Pacific. He worked closely with the other founders in various capacities during an eleven-year period at Sanne, which saw the business grow from a small, private company to a major international public company. Before Sanne, Martin worked at Babson Capital (now Barings) and Advent Ventures, overseeing finance and operations for private debt, private equity and venture capital funds. Martin qualified as a chartered accountant with KPMG.

 

James Ireland

James was formerly the CFO of Sanne Group plc for four and a half years until it was acquired in 2022. Prior to the successful sale of the group, he worked closely with Martin and the executive committee to build Sanne from c.1,000 people to 2,500 across 23 locations as well as being responsible for eight acquisitions and minority investments. Before Sanne, James worked within Investec plc's investment banking business where he led the Support Services sector team. This included working with Sanne on its IPO in 2015 and its subsequent acquisitions and capital raisings.

 

James Bermingham

James was Chief Legal Officer at Sanne Group plc, until its successful sale in 2022. Before that he was Group General Counsel at Aztec Group and founder of Aztec Luxembourg, which he very successfully managed for 9 years before being bought out in 2016. His professional background is an English solicitor and a Luxembourg avocat and has worked in the funds' industry for many years. His experience covers all aspects of fund structuring and regulatory compliance within industry, which are topics that he has spoken on and written about extensively.

 

Jason Bingham

Jason was formerly the Chief Strategy Officer of Sanne Group plc and worked in the firm for 10 years until it was acquired in 2022. With over 20 years' experience in the Private Capital industry, Jason has held various senior positions focused on commercial activities and leading client relationships. Previously, Jason worked within State Street's Alternative Investment Services business, where he led the private funds' offering in the UK. Jason qualified as a chartered company secretary with Mourant.

 

Phil Godley

Phil has worked as an advisor within the Private Capital industry since 2019. He has advised asset managers, data providers and service providers with regards commercial growth, data and AI. Prior to this, he was COO and an Executive Director of Sanne Group plc. At Sanne, he established the Private Debt and Capital Markets division in 2006 and became COO of Sanne in 2014 ahead of the IPO of the company in 2015. As a machine learning practitioner, he participates in competitive AI and seeks to advance the technology in areas such as natural language understanding.

 

 

MVIL Investment

Funds managed by Marwyn Investment Management LLP (the "Manager") have committed to invest £8 million in Palmer, of which approximately £6.2 million is attributable to the Ordinary shares of MVIL, representing 6.6% of the Ordinary share net asset value, measured at 30 April 2023, being the latest available NAV published by the Company.

 

Marwyn Value Investors Limited is a closed-ended investment company on the London Stock Exchange Specialist Fund Segment - a fully regulated market for professional, institutional and sophisticated investors. Marwyn's previous 11 comparable listed acquisition companies that have acquired platform businesses have gone on to make 83 subsequent transactions, delivering £3.5 billion in equity profits and an aggregate return to shareholders of 127 per cent on invested capital as at 30 April 2023. 

 

For further information see www.marwynvalue.com. Neither the content of the Company's website, nor the content on any website accessible from hyperlinks on its website for any other website, is incorporated into, or forms part of, this announcement nor, unless previously published by means of a recognised information service, should any such content be relied upon in reaching a decision as to whether or not to acquire, continue to hold, or dispose of, securities in the Company.

 

This announcement contains inside information for the purposes of Article 7 of the UK version of EU Regulation 596/2014 which forms part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended ("MAR"), and is disclosed in accordance with the Company's obligations under MAR. The person responsible for making this announcement is Robert Ware, Chairman, PO Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands. 

 

Investor Relations

Kam Bansil

Telephone: 020 7039 1901

 

Corporate Broker - Liberum Capital Limited

Chris Clarke / Owen Matthews

Telephone: 0203 100 2200

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCLZLLLXELBBBK
Date   Source Headline
2nd May 202410:10 amRNSNet Asset Value - 2021 Realisation Shares
2nd May 202410:05 amRNSNet Asset Value - 2016 Realisation Shares
2nd May 202410:00 amRNSNet Asset Value - Ordinary Shares
1st May 20247:00 amRNSInterim Dividend to Ordinary Shareholders
30th Apr 20242:56 pmRNSShare Dealings
30th Apr 20247:00 amRNSAnnual Financial Statements December 2023
22nd Apr 202411:00 amRNSNet Asset Values
15th Apr 202411:00 amRNSNet Asset Values
9th Apr 202410:10 amRNSNet Asset Value - 2021 Realisation Shares
9th Apr 202410:05 amRNSNet Asset Value - 2016 Realisation Shares
9th Apr 202410:00 amRNSNet Asset Value - Ordinary Shares
28th Mar 20243:26 pmRNSShare Transfer
21st Mar 20243:53 pmRNSNotification of Major Interests in Shares
21st Mar 20243:51 pmRNSNotification of Major Interests in Shares
20th Mar 20241:42 pmRNSShare Transfer
18th Mar 202411:00 amRNSNet Asset Values
11th Mar 202411:00 amRNSNet Asset Values
7th Mar 20241:52 pmRNSNotification of Major Interests in Shares
4th Mar 202410:10 amRNSNet Asset Value - 2021 Realisation Shares
4th Mar 202410:05 amRNSNet Asset Value - 2016 Realisation Shares
4th Mar 202410:00 amRNSNet Asset Value - Ordinary Shares
28th Feb 202410:10 amRNSNet Asset Value - 2021 Realisation Shares
28th Feb 202410:05 amRNSNet Asset Value - 2016 Realisation Shares
28th Feb 202410:00 amRNSNet Asset Value - Ordinary Shares
23rd Feb 202410:10 amRNSNet Asset Value - 2021 Realisation Shares
23rd Feb 202410:05 amRNSNet Asset Value - 2016 Realisation Shares
23rd Feb 202410:00 amRNSNet Asset Value - Ordinary Shares
14th Feb 202410:10 amRNSNet Asset Value - 2021 Realisation Shares
14th Feb 202410:05 amRNSNet Asset Value - 2016 Realisation Shares
14th Feb 202410:00 amRNSNet Asset Value - Ordinary Shares
2nd Feb 202410:10 amRNSNet Asset Value - 2021 Realisation Shares
2nd Feb 202410:05 amRNSNet Asset Value - 2016 Realisation Shares
2nd Feb 202410:00 amRNSNet Asset Value - Ordinary Shares
26th Jan 202410:10 amRNSNet Asset Value - 2021 Realisation Shares
26th Jan 202410:05 amRNSNet Asset Value - 2016 Realisation Shares
26th Jan 202410:00 amRNSNet Asset Value - Ordinary Shares
25th Jan 20247:00 amRNSInterim Dividend to Ordinary Shareholders
15th Jan 202410:10 amRNSNet Asset Value - 2021 Realisation Shares
15th Jan 202410:05 amRNSNet Asset Value - 2016 Realisation Shares
15th Jan 202410:00 amRNSNet Asset Value - Ordinary Shares
29th Dec 202310:10 amRNSNet Asset Value - 2021 Realisation Shares
29th Dec 202310:05 amRNSNet Asset Value - 2016 Realisation Shares
29th Dec 202310:00 amRNSNet Asset Value - Ordinary Shares
22nd Dec 202310:10 amRNSNet Asset Value - 2021 Realisation Shares
22nd Dec 202310:05 amRNSNet Asset Value - 2016 Realisation Shares
22nd Dec 202310:00 amRNSNet Asset Value - Ordinary Shares
18th Dec 20235:53 pmRNSShare Dealings
15th Dec 202311:42 amRNSNotification of Major Interests in Shares
14th Dec 20231:02 pmRNSResult of AGM
14th Dec 202310:10 amRNSNet Asset Value - 2021 Realisation Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.